SUN2 and cancer: In light of the evidence discussed above, when considering the potential for cancer therapies that target the nuclear envelope it is worth considering that due to the roles of some nuclear envelope proteins in DNA repair, these therapies may prove effective in combination with current DNA repair focused therapeutics, such as PARP inhibitors [87].